nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion
|
Son, Ji |
|
|
30 |
11 |
p. 1738-1747 |
artikel |
2 |
Advancing gynecologic oncology in Latin America through Project ECHO
|
Varon, Melissa Lopez |
|
|
30 |
11 |
p. 1840-1841 |
artikel |
3 |
A systematic review and meta-analysis of sarcopenia as a prognostic factor in gynecological malignancy
|
Allanson, Emma R |
|
|
30 |
11 |
p. 1791-1797 |
artikel |
4 |
Base rate of ovarian cancer on algorithms in patients with a pelvic mass
|
De Rolfsen, Anne Lone nny |
|
|
30 |
11 |
p. 1775-1779 |
artikel |
5 |
BRCA testing in women with high-grade serous ovarian cancer: gynecologic oncologist-initiated testing compared with genetics referral
|
Piedimonte, Sabrina |
|
|
30 |
11 |
p. 1757-1761 |
artikel |
6 |
Comparison of surgical and pathological parameters after laparoscopic transperitoneal pelvic/para-aortic lymphadenectomies
|
Jacob, Anna |
|
|
30 |
11 |
p. 1798-1802 |
artikel |
7 |
Correction: Clinical relevance of high–intermediate risk endometrial cancer according to European risk classification
|
|
|
|
30 |
11 |
p. 1852 |
artikel |
8 |
Correction: Location of recurrences in high-risk stage I endometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study
|
|
|
|
30 |
11 |
p. 1853 |
artikel |
9 |
Cost-effectiveness of robotic hysterectomy versus abdominal hysterectomy in early endometrial cancer
|
Lundin, Evelyn Serreyn |
|
|
30 |
11 |
p. 1719-1725 |
artikel |
10 |
Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective
|
Tsibulak, Irina |
|
|
30 |
11 |
p. 1667-1671 |
artikel |
11 |
Diagnostic accuracy of serum insulin-like growth factor-binding protein 2 for ovarian cancer
|
Prayudi, Pande Kadek Aditya |
|
|
30 |
11 |
p. 1762-1767 |
artikel |
12 |
Does iatrogenic tumor rupture during surgery have prognostic implications for the outcome of uterine sarcomas?
|
Benito, Virginia |
|
|
30 |
11 |
p. 1726-1732 |
artikel |
13 |
DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment
|
McMullen, Michelle |
|
|
30 |
11 |
p. 1824-1828 |
artikel |
14 |
Effective approaches towards eliminating cervical cancer from low-and middle-income countries amid COVID-19 pandemic
|
Rahman, Md Sazedur |
|
|
30 |
11 |
p. 1848-1849 |
artikel |
15 |
Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care
|
Norell, Charles H |
|
|
30 |
11 |
p. 1748-1756 |
artikel |
16 |
HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study
|
Andersen, Berit |
|
|
30 |
11 |
p. 1678-1683 |
artikel |
17 |
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva
|
Bartoletti, Michele |
|
|
30 |
11 |
p. 1672-1677 |
artikel |
18 |
Improving response to progestin treatment of low-grade endometrial cancer
|
Baxter, Eva |
|
|
30 |
11 |
p. 1811-1823 |
artikel |
19 |
Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review
|
Bona, Alberto Ferreira |
|
|
30 |
11 |
p. 1697-1704 |
artikel |
20 |
Laparoscopic complete resection of bulky precaval nodes by extraperitoneal approach in a patient with advanced endometrial cancer
|
Jaunarena, Ibon |
|
|
30 |
11 |
p. 1846-1847 |
artikel |
21 |
Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study – a multicentric analysis of predictors of failed mapping
|
Sozzi, Giulio |
|
|
30 |
11 |
p. 1713-1718 |
artikel |
22 |
Low value of staging in detecting extraovarian occult metastasis in mucinous borderline ovarian tumors
|
Jung, Hee-Jung |
|
|
30 |
11 |
p. 1780-1783 |
artikel |
23 |
Management of low-grade serous ovarian neoplasm in the setting of fertility preservation
|
Marchocki, Zibi |
|
|
30 |
11 |
p. 1834-1839 |
artikel |
24 |
More attention is needed for the corrigendum to the revised FIGO staging for carcinoma of the cervix uteri
|
Olthof, Ester P |
|
|
30 |
11 |
p. 1850 |
artikel |
25 |
Neoadjuvant chemotherapy for advanced ovarian cancer: the tail of the scorpion for radical debulking surgery?
|
Fotopoulou, Christina |
|
|
30 |
11 |
p. 1665-1666 |
artikel |
26 |
Non-invasive stereotactic ablative boost in patients with locally advanced cervical cancer
|
Dalwadi, Shraddha |
|
|
30 |
11 |
p. 1684-1688 |
artikel |
27 |
Orthotopic continent urinary diversion (the Budapest pouch) in 10 steps
|
Căpîlna, Mihai Emil |
|
|
30 |
11 |
p. 1842-1843 |
artikel |
28 |
Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes
|
Pietragalla, Antonella |
|
|
30 |
11 |
p. 1803-1810 |
artikel |
29 |
Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer
|
Chelariu-Raicu, Anca |
|
|
30 |
11 |
p. 1768-1774 |
artikel |
30 |
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer
|
Slomovitz, Brian M |
|
|
30 |
11 |
p. 1733-1737 |
artikel |
31 |
Physical activity trajectories following gynecological cancer: results from a prospective, longitudinal cohort study
|
Fleming, Steven |
|
|
30 |
11 |
p. 1784-1790 |
artikel |
32 |
Prediction scoring system based on clinicohematologic parameters for cervical cancer patients undergoing chemoradiation
|
Kim, Youn Ji |
|
|
30 |
11 |
p. 1689-1696 |
artikel |
33 |
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)
|
Fagotti, Anna |
|
|
30 |
11 |
p. 1657-1664 |
artikel |
34 |
Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010)
|
Tu, Hua |
|
|
30 |
11 |
p. 1829-1833 |
artikel |
35 |
Tertiary cytoreductive surgery by laparoscopy in granulosa cell tumor recurrence
|
García Pineda, Virginia |
|
|
30 |
11 |
p. 1844-1845 |
artikel |
36 |
Tumor size in cervical cancer: an ongoing dilemma
|
Salvo, Gloria |
|
|
30 |
11 |
p. 1851 |
artikel |
37 |
Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer
|
De Cuypere, Marjolein |
|
|
30 |
11 |
p. 1705-1712 |
artikel |